DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma

Published:2019-01-14 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Evelönn Emma Andersson,Landfors Mattias,Haider Zahra,Köhn Linda,Ljungberg Börje,Roos Göran,Degerman Sofie^ORCID

Funder

Medicinska fakulteten, Umeå Universitet

Lion's Cancer Research Foundation, Umeå

Kempestiftelserna

Cancerfonden

Västerbotten Läns Landsting

Uppsala-Umeå Comprehensive Cancer Consortium

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5291-3.pdf

Reference57 articles.

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. https://doi.org/10.3322/caac.21208 .

2. Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34(8):1081–6. https://doi.org/10.1007/s00345-016-1773-y .

3. Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the National Swedish Kidney Cancer Register. Scand J Urol. 2014;48(3):231–8. https://doi.org/10.3109/21681805.2013.864698 .

4. Greene FL, Sobin LH. The TNM system: our language for cancer care. J Surg Oncol. 2002;80(3):119–20. https://doi.org/10.1002/jso.10114 .

5. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6(7):655–63.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ITGB3 is a Novel Prognostic Biomarker and Correlates with Aberrant Methylation and Tumor Immunity in Clear Cell Renal Cell Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-08-12

2. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness;Cancer Cell;2023-01

3. Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework;Science Advances;2022-09-30

4. Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma;Frontiers in Genetics;2022-08-30

5. Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis;Frontiers in Immunology;2022-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3